Titlebook: Management of Breast Cancer in Older Women; Malcolm Reed,Riccardo A. Audisio Book 2019Latest edition Springer Nature Switzerland AG 2019 T

和善

書目名稱Management of Breast Cancer in Older Women影響因子(影響力)




書目名稱Management of Breast Cancer in Older Women影響因子(影響力)學科排名




書目名稱Management of Breast Cancer in Older Women網(wǎng)絡公開度




書目名稱Management of Breast Cancer in Older Women網(wǎng)絡公開度學科排名




書目名稱Management of Breast Cancer in Older Women被引頻次




書目名稱Management of Breast Cancer in Older Women被引頻次學科排名




書目名稱Management of Breast Cancer in Older Women年度引用




書目名稱Management of Breast Cancer in Older Women年度引用學科排名




書目名稱Management of Breast Cancer in Older Women讀者反饋




書目名稱Management of Breast Cancer in Older Women讀者反饋學科排名

offense

Adjuvant Endocrine Therapy,n and sequencing of ET in post-menopausal women, which can assist clinicians in their recommendations to elderly patients. This chapter will summarise the findings of these seminal trials, and their applicability to the elderly subpopulation will be discussed.

吞噬

,Nurses’ Role in Care of Older Women with Breast Cancer,e including, but not limited to, providing clinical care, to psychosocial support, to helping patients navigate the system. This chapter will highlight the importance of nurses in providing care for older women with breast cancer through their trajectory of care.

船員

膝蓋

Book 2019Latest editionatients with breast cancer. It presents the most up-to-date research and clinical practice from? leading specialists across a range of fields that come into contact with older breast cancer patients..?.With new chapters on nursing and clinical trials in older women, as well as patient perspectives a

禁止

補充

Heresy

Primary Endocrine Therapy,is setting. Primary endocrine therapy is well tolerated and may avoid unnecessary morbidity for some women if selected appropriately. At present there are no evidence based selection guidelines but it is hoped these will be published soon once the Age Gap trial reports.

Delude

CRASS

Medical Management of Advanced Disease,s and agents is dependent on individual patient characteristics, preferences, and drug availability. Targeted treatments are used more and more, and also in older persons they can provide major clinical benefit with acceptable safety profile.